◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › P › PBH

Prestige Brand Holdings Inc (PBH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-09-04

Prestige Brand Holdings Inc (PBH) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Tarrytown, United States with about 890 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2026-03-31, PBH reported $1.1B in revenue and $190M in net income.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Interactive charts & full statements → Open the PBH valuation workbench →

PBH Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Revenue	$1.1B	$1.1B	$1.1B	$1.1B	$1.1B	$1.1B	$943M	$963M	$976M	$1.0B	$882M	$806M	$715M	$602M	$624M	$441M	$337M	$302M	$313M	$327M	$319M
Gross Profit	$588M	$575M	$634M	$624M	$625M	$621M	$547M	$552M	$556M	$577M	$500M	$467M	$406M	$340M	$347M	$227M	$171M	$157M	$163M	$169M	$165M
Gross Margin %	53.3%	52.8%	55.8%	55.5%	55.5%	57.1%	58.0%	57.3%	56.9%	55.4%	56.7%	58.0%	56.8%	56.5%	55.7%	51.5%	50.8%	52.1%	52.2%	51.6%	51.9%
Operating Income (EBIT)	$290M	$309M	$337M	$342M	($22M)	$330M	$297M	$291M	$68M	$216M	$206M	$260M	$208M	$189M	$192M	$103M	$76M	$79M	($168M)	$91M	$95M
Operating Margin %	26.3%	28.4%	29.6%	30.4%	-2.0%	30.4%	31.5%	30.2%	6.9%	20.7%	23.3%	32.3%	29.0%	31.3%	30.8%	23.3%	22.6%	26.1%	-53.6%	28.0%	29.7%
Net Income	$172M	$190M	$215M	$209M	($82M)	$205M	$165M	$142M	($36M)	$340M	$69M	$100M	$78M	$73M	$66M	$37M	$29M	$32M	($187M)	$34M	$36M
Net Margin %	15.6%	17.5%	18.9%	18.6%	-7.3%	18.9%	17.5%	14.8%	-3.7%	32.6%	7.9%	12.4%	10.9%	12.1%	10.5%	8.4%	8.7%	10.6%	-59.7%	10.4%	11.3%
EBITDA	$313M	$331M	$362M	$374M	$8M	$359M	$317M	$325M	$99M	$356M	$304M	$266M	$227M	$184M	$204M	$113M	$86M	$85M	($156M)	$105M	$95M
Earnings Per Share (EPS)	$3.57	$3.91	$4.29	$4.17	$-1.65	$4.04	$3.25	$2.78	$-0.69	$6.34	$1.30	$1.88	$1.49	$1.39	$1.27	$0.73	$0.58	$0.64	$-3.74	$0.68	$0.72
Shares Outstanding (M)	48M	49M	50M	50M	50M	51M	51M	51M	52M	54M	53M	53M	53M	52M	51M	51M	50M	50M	50M	50M	50M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PBH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$266M	$282M	$283M	$274M	$250M	$297M	$290M	$284M
Gross Profit	$136M	$141M	$157M	$154M	$135M	$176M	$161M	$157M
Gross Margin %	51.2%	50.0%	55.5%	56.2%	54.2%	59.2%	55.5%	55.5%
Operating Income (EBIT)	$53M	$75M	$82M	$80M	$72M	$88M	$92M	$84M
Operating Margin %	19.8%	26.8%	29.1%	29.1%	28.8%	29.8%	31.7%	29.7%
Net Income	$29M	$54M	$47M	$42M	$47M	$50M	$61M	$54M
Net Margin %	11.0%	19.1%	16.5%	15.4%	19.0%	16.9%	21.0%	19.2%
EBITDA	$61M	$85M	$80M	$87M	$80M	$92M	$98M	$90M
Earnings Per Share (EPS)	$0.61	$1.13	$0.97	$0.86	$0.95	$1.00	$1.22	$1.09
Shares Outstanding (M)	48M	48M	48M	49M	50M	50M	50M	50M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PBH Free Cash Flow History

Cash flow	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Cash from Operations (CFO)	$249M	$258M	$252M	$249M	$230M	$260M	$236M	$217M	$189M	$210M	$148M	$174M	$156M	$112M	$138M	$67M	$87M	$59M	$67M	$45M	$72M
Capital Expenditures (CapEx)	$14M	$11M	$8M	$10M	$8M	$10M	$22M	$15M	$10M	$13M	$3M	$4M	$6M	$3M	$10M	$1M	$1M	$1M	$0M	$1M	$1M
Free Cash Flow (FCF)	$235M	$246M	$243M	$239M	$222M	$250M	$213M	$203M	$179M	$198M	$145M	$171M	$150M	$109M	$127M	$67M	$86M	$59M	$66M	$44M	$71M
FCF Margin %	21.3%	22.6%	21.4%	21.3%	19.7%	23.0%	22.6%	21.0%	18.3%	19.0%	16.4%	21.2%	21.0%	18.1%	20.4%	15.2%	25.6%	19.4%	21.2%	13.6%	22.4%
Dividends Paid	—	—	—	—	—	$4M	$3M	$1M	$3M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PBH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$71M	$43M	$78M	$57M	$79M	$62M	$65M	$70M
Capital Expenditures (CapEx)	$4M	$5M	$3M	$2M	$1M	$3M	$2M	$2M
Free Cash Flow (FCF)	$67M	$38M	$75M	$55M	$78M	$58M	$64M	$68M
FCF Margin %	25.2%	13.4%	26.6%	20.2%	31.3%	19.7%	21.9%	23.9%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PBH Balance Sheet History

Balance sheet	2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Assets	$4.6B	$3.5B	$3.4B	$3.3B	$3.4B	$3.7B	$3.4B	$3.5B	$3.4B	$3.8B	$3.9B	$2.9B	$2.7B	$1.8B	$1.7B	$1.8B	$1.1B	$791M	$801M	$1.0B	$1.1B
Cash & Cash Equivalents	$89M	$64M	$98M	$46M	$58M	$27M	$32M	$95M	$28M	$33M	$42M	$27M	$21M	$28M	$16M	$19M	$13M	$41M	$35M	$6M	$14M
Total Liabilities	$2.7B	$1.7B	$1.6B	$1.7B	$1.9B	$2.1B	$2.1B	$2.3B	$2.3B	$2.6B	$3.1B	$2.2B	$2.0B	$1.2B	$1.3B	$1.4B	$695M	$462M	$507M	$570M	$618M
Total Debt (Short + Long-Term)	$2.0B	$1.0B	$1.0B	$1.1B	$1.4B	$1.5B	$1.5B	$1.7B	$1.8B	$4.0B	$2.2B	$1.6B	$3.1B	$1.9B	$971M	$1.1B	$487M	$324M	$378M	$411M	$463M
Total Shareholders' Equity	$1.9B	$1.9B	$1.8B	$1.7B	$1.4B	$1.6B	$1.4B	$1.2B	$1.1B	$1.2B	$823M	$744M	$628M	$563M	$478M	$403M	$362M	$329M	$294M	$479M	$445M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PBH viewer.

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

SUPN · Supernus Pharmaceuticals Inc — $2 billion
HCM · HUTCHMED DRC — $2 billion
BCRX · BioCryst Pharmaceuticals Inc — $2 billion
TRLV · Trulieve Cannabis Corp. — $2 billion
BHC · Bausch Health Companies Inc — $2 billion
ALVO · Alvotech — $2 billion
PRGO · Perrigo Company PLC — $2 billion
ANIP · ANI Pharmaceuticals Inc — $2 billion

← PBFS All “P” companies PBHC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.